After the close of trading Thursday, Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) announced that the FDA has approved ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE